People with HIV in Ontario still dying at higher rates than the general population.
Courtesy of St. Michael's Hospital
Dr. Sean Rourke, a neuropsychologist at St. Michael's Hospital and scientist at its Centre for Urban Health Solutions,
TORONTO, March 19, 2018 -- People who are living with HIV in Ontario have access to good health care and medications, yet they are still dying younger and at substantially higher rates than the rest of the population, according to a new study published today.
The findings suggest that the overall well-being of these people is being neg
Workshops are held in person at the Specialty Legal Clinic Co-op, 55 University Avenue, 15th Floor Room C2, Toronto (just south of King Street West and the fully accessible St. Andrew subway station):
The HIV & AIDS Legal Clinic Ontario (HALCO) is pleased to announce our next series of free Public Legal Education Workshops taking place in person at our office in May and June 2018.
Everyone is welcome to attend any of these general interest workshops but space is limited so Registration is required.
How to Register:
Please include your name, your contact information, your organization (if any), and the titles of the workshop(s) that you would like to attend:
– Email to T
UNAIDS press statement released ahead of World TB Day, 2018: "TB is the leading cause of death among people living with HIV."
Credit: MSF/Luca Sola
GENEVA, 23 March 2018—Ahead of World TB Day 2018, UNAIDS is calling on all partners to take unprecedented and bold action to advance efforts to end tuberculosis (TB) and AIDS by 2030.
TB continues to be the top infectious killer worldwide, claiming more than 4500 lives a day. TB is also the leading cause of death among people living with HIV, causing one in three AIDS-related deaths. In 2016, 1.7 million people died from TB, including around 374 000 people living wi
Gilead Canada supports community leaders with local Hepatitis C micro-elimination efforts.
Mississauga, ON, March 14, 2018 – In support of Canada’s commitment to the World Health Organization’s (WHO) goal of eliminating chronic hepatitis C infection by 2030, Gilead Sciences Canada, Inc. (Gilead Canada) today announced a series of grants to support screening and linkage to care projects across Canada. These initiatives will focus on hepatitis C screening within high-risk patient populations and linking diagnosed patients to care. In total, 13 Hepatitis C Micro-Elimination Gran
From HIV Justice Worldwide: "...an important step towards realizing a world where people living with HIV are not singled out by the criminal justice system simply for having a virus.“
When it comes to the widely misunderstood, complex issue of HIV criminalisation, media can be a powerful tool–or a blunt-force weapon.
And so today, as people around the world living with HIV continue to be criminalised and convicted at alarming rates, HIV JUSTICE WORLDWIDE has released “Making Media Work for HIV Justice: An introduction to media engagement for advocates opposing HIV criminalisation.”
The new resource is the latest addition to the HIV JUSTICE Toolkit, which provides
The service is a response to the ongoing Bruce McArthur investigation, creators say
Haran Vijayanathan says the program will be useful 'whether it’s a hookup or a date or somebody who you’re meeting for the first time.' (Nick Boisvert/CBC)
A Toronto-based community health organization has launched a new service that can confirm someone's whereabouts and well-being after a date with a stranger. The creators of the Alliance for South Asian AIDS Prevention's (ASAAP) SAFE program say it will be particularly useful to LGBT people from marginalized communities.
"When we sa
Successful appeal to state government got ‘cap’ lifted on PrEP demo trial. From AIDSmap, Gus Cairns reports.
The state of New South Wales in Australia has seen a fall of one-third in diagnoses of recent HIV infection since it started its pre-exposure prophylaxis (PrEP) implementation project, EPIC-NSW (Expanded PrEP Implementation in the Community), the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) heard last week.
Andrew Grulich of the Kirby Institute of the University of New South Wales told the conference that only two people who entered EPIC-NSW had been diagnosed wi
"... researchers indicated that time from schizophrenia diagnoses to death was significantly short for those with HIV than those without." From MD Mag, Kevin Kunzmann reports.
There is a six-fold prevalence of schizophrenia in people with HIV than that of the population without the virus, according to the results of a Vancouver, BC, Canada-based study. The study, presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, MA, this week, found a distinct association between the mental disorder and HIV — a relationship sparsely analyzed before. Researchers from the British Columbia Centre for Excellence in HIV/AIDS in Vancouver,
From AIDSmap, Gus Cairns reports from the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018).
A study presented at the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) aims to quantify how many people with HIV there might be in the community who both have a detectable HIV viral load and also have significant resistance to tenofovir and emtricitabine, the two drugs currently used in pre-exposure prophylaxis (PrEP).
The researchers, from the University of Washington in Seattle, found that in King County, which contains Seattle, no more than 0.3% of the l
From AIDSmap, Michael Carter and Keith Alcorn report on the Rakai Community Cohort Study.
The rate of new HIV infections has halved since 2011 in a Ugandan community following large increases in male circumcision, antiretroviral treatment and viral suppression, Frank Kagaayi of the Rakai Health Sciences Program told the Conference on Retroviruses and Opportunistic Infections in Boston on Tuesday.
Dr Kagaayi was presenting results from the Rakai Community Cohort Study, focusing on repeat surveys of one fishing village with a very high prevalence and incidence of HIV infection. The
Five of eleven treated animals still remained virally suppressed at six months. From AIDSmap, Liz Highleyman reports.
Dan Barouch presenting at CROI 2018. Photo by Liz Highleyman
Treatment with a broadly neutralising antibody plus an immune-stimulating drug led to long-term viral remission after interrupting antiretroviral therapy in a monkey study, according to data presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) this week in Boston.
Monkeys that received both the antibody, known as PGT121, and the TLR7 agonist GS-9620 maintained an undetectable viral load withou
Good news for those infected or co-infected with Hepatitis C in Ontario
- Gilead applauds Ontario’s Ministry of Health for expanding access to curative hepatitis C therapies to all diagnosed patients, regardless of severity of illness
- Ontario’s expanded access includes EPCLUSA®, a 12 week treatment for patients with chronic hepatitis C across all six genotypes
- Gilead’s new product, VOSEVI™ is now available under the Ontario Drug Benefit Program
- The removal of the fibrosis level criterion for access furthers Canada’s commitment to the World Heal
From AIDSmap, Keith Alcorn reports on two studies assessing the influence of provider type on outcomes of chronic co-morbidities in HIV.
People with HIV who have other medical conditions such as high blood pressure or high lipids appear to do better if they have a primary care physician as well as an HIV physician, according to a study of people receiving care through UCLA Center for Clinical AIDS Research and Education, researchers report in The Journal of Infectious Diseases.
A second study, looking at chronic medical conditions, or co-morbidities, in a large sample of people with HIV in the United States found that high b